1.Clinical association between intensive antihypertensive therapy and post-stroke depression in patients with acute ischemic stroke
Journal of Apoplexy and Nervous Diseases 2023;40(9):802-806
Objective To investigate the effect of antihypertensive therapy on post-stroke depression (PSD) in patients with acute ischemic stroke. Methods A total of 83 patients who were diagnosed with ischemic stroke by computed tomography or brain magnetic resonance imaging within 48 hours after the appearance of symptoms from August 2020 to January 2022 were enrolled in this study, and they were divided into intensive antihypertensive therapy group (intensive group with 41 patients) and standard antihypertensive therapy group (standard group with 42 patients) using a random number table. The goal of the intensive group was to reduce systolic blood pressure to <130 mmHg, and the goal of the standard group was to reduce systolic blood pressure to <140 mmHg. The primary outcome was the incidence rate of PSD during follow-up for 6 months after treatment, which was defined as ≥8 points for Hamilton Rating Scale for Depression-24 Items (HRSD-24), and secondary outcomes were cognitive tests [Addenbrooke's Cognitive Examination Revised (ACE-R) and Stroop test] and activities of daily living (Barthel Index). The safety outcome was a serious adverse event. Results After 6 months of treatment, compared with the relative changes of systolic blood pressure and diastolic blood pressure in the standard group, the systolic blood pressure and diastolic blood pressure in the intensive group were reduced by 10.6 mmHg and 5.5 mmHg, respectively (P<0.001 and P=0.004). In addition, the relative change of heart rate during treatment in the intensive group was reduced by 5.0 bmp compared with that in the standard group (P=0.034). After adjustment for random variables, there was no significant difference in the primary outcome (HRSD score) between the intensive group and the standard group during the treatment period, and HRSD score in the intensive group was reduced by 1.2 (95%CI -0.8 to 1.1, P=0.105). As for the secondary outcomes, compared with the standard group, the intensive group had significant reductions in ACE-R (P=0.045) and mRS (P=0.036) and significant increases in the scores of accuracy (P=0.027), interference accuracy (P=0.033), and animal naming (P=0.008) in Stroop test. There was no significant difference in the overall incidence rate of serious adverse events between the two groups at the end of the trial (χ2=0.597, P=0.440). Conclusion Intensive antihypertensive therapy has an acceptable safety profile in patients with acute ischemic stroke, but it cannot reduce the risk of PSD.
2.Study on the trend of menarche age in Han and Mongolian women born from 1951 to 2005 in Mongolian region
Guoyan DENG ; Yangguang SONG ; Nashun HU ; Ruihao XU ; Liwen SUN ; Jinhua BAO ; Guirong HUO ; Yulan CHEN ; Yuping XU ; Bala CHEN ; Bin ZHANG ; Shangming WANG ; Shucheng ZHANG
Chinese Journal of Reproduction and Contraception 2023;43(8):834-841
Objective:To study the trend of menarche age in Han and Mongolian women born from 1951 to 2005 in Mongolian region.Methods:A cross-sectional cluster sampling survey method was adopted, From 2003 to 2019, a retrospective survey was carried out in three banners/counties in Tongliao region on the female population of Han and Mongols nationalities aged 16 to 46 and conducted under standardized survey procedures and quality control standards. The basic data of menarche age of women born between 1951 and 2005 were obtained. The changes and rules were analyzed by taking 1 year, 5 years and 10 years as nodes.Results:Totally 46 and conducted under standardized survey procedures and quality control standards 928 pepole (24 450 Han and 22 478 Mongolian) were recruited, the survey response rate was 96.09% (46 928/48 836). In one-year-period analysis, the menarche age gradually decreased from 1951 to 2005. The mean menarche age of Han and Mongolian women changed from (16.22±0.52) years and (15.86±1.24) years in 1951 to (12.37±1.15) years and (12.33±0.98) years in 2005, respectively. The mean menarche age of Han and Mongolian women decreased 3.85 years and 3.54 years. The trend of the mean menarche age's change showed a significant negative correlation with the years (all P<0.000 1). In five-year-period analysis, the mean menarche age of Han and Mongolian women changed from (15.54±1.45) years and (15.53±1.48) years from 1951 to 1955 to (12.41±0.97) years and (12.47±0.96) years from 2001 to 2005, the mean menarche age decreased 3.13 years (3.41 months ahead of schedule every 5 years on average) and 3.06 years (3.34 months ahead of schedule every 5 years on average) in Han and Mongolian women respectively. In ten-year-period analysis, the mean menarche age of Han and Mongolian women changed from (15.79±0.95) years and (15.53±1.33) years from 1951 to 1960 to (12.41±0.97) years and (12.47±0.96) years from 2001 to 2005, the mean menarche age decreased 3.38 years (6.76 months ahead of schedule every 10 years on average) and 3.06 years (6.12 months ahead of schedule every 10 years on average) in Han and Mongolian women respectively. During the 15 years from 1951 to 1965, 1966 to 1970, 1971 to 1990, and 1991 to 2000, they were concentrated at the ages of 15-16, 14-15, 13-14, and 12-13, respectively. The proportion of women at 11 years, 12 years and 13 years menarche age were 26.79% (457/1 706), 73.27% (1 250/1 706), and 92.85% (1 584/1 706) during 2001—2005 in Han women, while the proportion were 23.25% (653/2 809), 62.01% (1 742/2 809), and 90.14% (2 532/2 809) in Mongolian women. Conclusion:The menarche age decreased in Han and Mongolian women from 1951 to 2005, and the ethnic groups tended to be the same. It is recommended to start adolescent education at the age of 8-9 years and pay attention to the changing pattern of early onset of menarche.
3.Study on the trend of menarche age in Han and Mongolian women born from 1951 to 2005 in Mongolian region
Guoyan DENG ; Yangguang SONG ; Nashun HU ; Ruihao XU ; Liwen SUN ; Jinhua BAO ; Guirong HUO ; Yulan CHEN ; Yuping XU ; Bala CHEN ; Bin ZHANG ; Shangming WANG ; Shucheng ZHANG
Chinese Journal of Reproduction and Contraception 2023;43(8):834-841
Objective:To study the trend of menarche age in Han and Mongolian women born from 1951 to 2005 in Mongolian region.Methods:A cross-sectional cluster sampling survey method was adopted, From 2003 to 2019, a retrospective survey was carried out in three banners/counties in Tongliao region on the female population of Han and Mongols nationalities aged 16 to 46 and conducted under standardized survey procedures and quality control standards. The basic data of menarche age of women born between 1951 and 2005 were obtained. The changes and rules were analyzed by taking 1 year, 5 years and 10 years as nodes.Results:Totally 46 and conducted under standardized survey procedures and quality control standards 928 pepole (24 450 Han and 22 478 Mongolian) were recruited, the survey response rate was 96.09% (46 928/48 836). In one-year-period analysis, the menarche age gradually decreased from 1951 to 2005. The mean menarche age of Han and Mongolian women changed from (16.22±0.52) years and (15.86±1.24) years in 1951 to (12.37±1.15) years and (12.33±0.98) years in 2005, respectively. The mean menarche age of Han and Mongolian women decreased 3.85 years and 3.54 years. The trend of the mean menarche age's change showed a significant negative correlation with the years (all P<0.000 1). In five-year-period analysis, the mean menarche age of Han and Mongolian women changed from (15.54±1.45) years and (15.53±1.48) years from 1951 to 1955 to (12.41±0.97) years and (12.47±0.96) years from 2001 to 2005, the mean menarche age decreased 3.13 years (3.41 months ahead of schedule every 5 years on average) and 3.06 years (3.34 months ahead of schedule every 5 years on average) in Han and Mongolian women respectively. In ten-year-period analysis, the mean menarche age of Han and Mongolian women changed from (15.79±0.95) years and (15.53±1.33) years from 1951 to 1960 to (12.41±0.97) years and (12.47±0.96) years from 2001 to 2005, the mean menarche age decreased 3.38 years (6.76 months ahead of schedule every 10 years on average) and 3.06 years (6.12 months ahead of schedule every 10 years on average) in Han and Mongolian women respectively. During the 15 years from 1951 to 1965, 1966 to 1970, 1971 to 1990, and 1991 to 2000, they were concentrated at the ages of 15-16, 14-15, 13-14, and 12-13, respectively. The proportion of women at 11 years, 12 years and 13 years menarche age were 26.79% (457/1 706), 73.27% (1 250/1 706), and 92.85% (1 584/1 706) during 2001—2005 in Han women, while the proportion were 23.25% (653/2 809), 62.01% (1 742/2 809), and 90.14% (2 532/2 809) in Mongolian women. Conclusion:The menarche age decreased in Han and Mongolian women from 1951 to 2005, and the ethnic groups tended to be the same. It is recommended to start adolescent education at the age of 8-9 years and pay attention to the changing pattern of early onset of menarche.
4.Clinical effects of photo-activated disinfection as an adjunctive therapy for the treatment of chronic periodontitis
Shucheng HU ; Rong SHU ; Zhongchen SONG ; Mengjun SUN ; Yiwei WANG
Journal of Shanghai Jiaotong University(Medical Science) 2017;37(5):621-626
Objective · To investigate the clinical effects of photo-activated disinfection (PAD)-assisted non-surgical therapy on the treatment of chronic periodontitis. Methods · Eleven patients with chronic periodontitis (totally 118 selected sites) were randomly enrolled. A split-mouth self-control method was adopted. Selected sites with the probing depth (PD) of bilateral homonymous teeth ≥ 5 mm were randomly assigned to the group A (receiving scaling and root planning, SRP) and the group B (receiving SRP+ PAD). Periodontal clinical indexes, inflammation indexes, and periodontal pathogens at selected sites were examined at baseline and 6 and 12 weeks after treatment. Results · Both SRP alone and SRP+PAD improved the periodontal inflammation significantly. The positive rate of bleeding on probing (BOP) 12 weeks after treatment was remarkably lower in the group B than in the group A (37.3% vs 57.6%, P=0.042). Both SRP and SRP+PAD effectively decreased matrix metalloproteinase-8 (MMP-8) and interleukin-1β (IL-1β) levels in gingival crevicular fluid. The IL-1β levels 6 and 12 weeks after treatment were significantly lower in the group B than in the group A [(17.99±14.26) pg/mL vs (32.64±30.69) pg/mL, P=0.007; (11.37±10.25) pg/mL vs (23.85±15.55) pg/mL, P=0.000]. Both treatments decreased the ratio of P. gingivalis and F.nucleatum in total bacteria. Conclusion · PAD can serve as a potential adjunctive therapy to conventional SRP in the treatment of chronic periodontitis with better improvement of bleeding gums and control of periodontal inflammation.
5.Endoscopic surgery of complicated deflection of nasal septum in 52 cases.
Zhengjuan ZHOU ; Ming HU ; Zhongzhu PAN ; Jianjun YU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2012;26(8):367-369
OBJECTIVE:
To discuss the clinic effect and surgical experience of complicated deflection of nasal septum with endoscopic surgery.
METHOD:
Fifty-two patients with complicated deflection of nasal septum were diagnosed by nasal endoscopy and CT scan,such as posterior segment deflection, huge processus spinosus, multi-abnormal curvature, nasal septum fracture dislocation and second operation for deflection of nasal septum. All case were followed-up for six months,
RESULT:
All case had satisfactory surgical results. All had an unobstructed nasal cavity and no perforation of nasal septum, nasal synechia and bridge of nose collapsed.
CONCLUSION
Endoscopic surgery in complicated deflection of nasal septum have the good advantages of vision and accuracy. So the endoscopic surgery is a minimally invasive surgery and benefit to the nasal physiological function.
Adolescent
;
Adult
;
Endoscopy
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nasal Septum
;
abnormalities
;
surgery
;
Treatment Outcome
;
Young Adult


Result Analysis
Print
Save
E-mail